A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
In women with 2 or more unexplained miscarriages, aspirin therapy alone or in combination with the low-molecular-weight heparin derivative nadroparin does not increase the live-birth rate, relative to placebo, despite its widespread use for this purpose.
That is according to the randomized placebo-controlled Anticoagulants for Living Fetuses (ALIFE) study, published online March 24 in the New England Journal of Medicine.
job as Research Scientist-Analytical Development Lab